We are live on ! Find out more
BC

Barrett & Company Portfolio holdings

AUM $357M
1-Year Est. Return 22.45%
This Fund
S&P 500
This Quarter Est. Return
+7.91%
1 Year Est. Return
+22.45%
3 Year Est. Return
+74.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$151M
AUM Growth
$0
Cap. Flow
-$69.9K
Cap. Flow %
-0.05%
Top 10 Hldgs %
33.86%
Holding
590
New
–
Increased
–
Reduced
2
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CPRT icon
Copart
CPRT
+$68.3K
2
NGG icon
National Grid
NGG
+$1.6K

Sector Composition

Rank Sector Weight
1 Financials 7.87%
2 Technology 6.34%
3 Healthcare 5.38%
4 Industrials 4.47%
5 Consumer Discretionary 2.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NID
476
DELISTED
NUVEEN INTERMEDIATE DURATION MUNICIPAL TERM FUND
NID
$3.28K ﹤0.01%
250
– –
IR icon
477
Ingersoll Rand
IR
$34.2B
$3.24K ﹤0.01%
62
– –
GSG icon
478
iShares S&P GSCI Commodity-Indexed Trust
GSG
$968M
$3.19K ﹤0.01%
150
– –
ICLN icon
479
iShares Global Clean Energy ETF
ICLN
$2.37B
$3.18K ﹤0.01%
160
– –
SCHZ icon
480
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
$3.15K ﹤0.01%
138
– –
XYZ
481
Block Inc
XYZ
$47.5B
$3.14K ﹤0.01%
50
– –
HST icon
482
Host Hotels & Resorts
HST
$16B
$3.13K ﹤0.01%
195
– –
IUSV icon
483
iShares Core S&P US Value ETF
IUSV
$27.5B
$3.04K ﹤0.01%
43
– –
EUSB icon
484
iShares ESG Advanced Universal USD Bond ETF
EUSB
$711M
$2.95K ﹤0.01%
70
– –
CGCP icon
485
Capital Group Core Plus Income ETF
CGCP
$8.42B
$2.94K ﹤0.01%
132
– –
HPQ icon
486
HP
HPQ
$25.8B
$2.93K ﹤0.01%
109
– –
NVCR icon
487
NovoCure
NVCR
$1.83B
$2.93K ﹤0.01%
40
– –
EGRX
488
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$2.92K ﹤0.01%
100
– –
CHX
489
DELISTED
ChampionX
CHX
$2.9K ﹤0.01%
100
– –
ARKF icon
490
ARK Blockchain & Fintech Innovation ETF
ARKF
$750M
$2.85K ﹤0.01%
200
– –
TRU icon
491
TransUnion
TRU
$15.2B
$2.84K ﹤0.01%
50
– –
JD icon
492
JD.com
JD
$44.3B
$2.81K ﹤0.01%
50
– –
IWM icon
493
iShares Russell 2000 ETF
IWM
$82.1B
$2.79K ﹤0.01%
16
– –
ACGL icon
494
Arch Capital
ACGL
$33.9B
$2.76K ﹤0.01%
44
– –
XLU icon
495
State Street Utilities Select Sector SPDR ETF
XLU
$22.4B
$2.76K ﹤0.01%
78
– –
CC icon
496
Chemours
CC
$2.27B
$2.76K ﹤0.01%
90
– –
IFF icon
497
International Flavors & Fragrances
IFF
$21.6B
$2.73K ﹤0.01%
26
– –
ZTO icon
498
ZTO Express
ZTO
$18.3B
$2.64K ﹤0.01%
98
– –
ESGU icon
499
iShares ESG Aware MSCI USA ETF
ESGU
$18.3B
$2.63K ﹤0.01%
31
– –
GOVT icon
500
iShares US Treasury Bond ETF
GOVT
$43.5B
$2.59K ﹤0.01%
114
– –
18 19
20
21 22

Similar funds

RM
Rudius Management New York $358M AUM 12.23% 1-Year Est. Return
CCM
Contrarian Capital Management Greenwich, Connecticut $357M AUM 18.27% 1-Year Est. Return
HP
Holowesko Partners Nassau, Bahamas $357M AUM 15.03% 1-Year Est. Return
GM
Granger Management New York $358M AUM 18.36% 1-Year Est. Return
LSWP
Liberty Square Wealth Partners Bethlehem, Pennsylvania $358M AUM 17% 1-Year Est. Return
SPM
Symmetry Peak Management Radnor, Pennsylvania $359M AUM 146.87% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 8.03% 1-Year Est. Return

Barrett & Company's Q4 2022 Portfolio in Review

As of Q4 2022, Barrett & Company held 590 positions worth $151M, unchanged from the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 0%. Barrett & Company opened no new positions and made no exits, leaving the 590-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 7.9% of assets, unchanged from a quarter earlier, followed by Technology and Healthcare.

  • Barrett & Company's biggest Q4 2022 reduction was Copart, cutting an estimated $68.3K.
  • Barrett & Company's ten largest holdings make up 34% of its $151M portfolio in Q4 2022.
  • Barrett & Company opened 0 new positions and closed 0 in Q4 2022.
  • Barrett & Company's portfolio value was unchanged quarter-over-quarter at $151M.

Based on Barrett & Company's 13F filing for Q4 2022, filed 23 May 2023.